IndraLab
Statements
Hydroxychloroquine inhibits Malaria. 13 / 15
2
|
6
7
reach
"This was hydroxychloroquine, used to treat the symptoms of SLE and rheumatoid arthritis (RA) and to prevent and treat malaria, that reduced cellularity to 4.64 × 10 cells/mL in average (p = 0.0002), and FTY720, used to treat relapsing forms of multiple sclerosis, that reduced cellularity to 2.43 × 10 cells/mL in average (p < 0.0001)."
reach
"However, another retrospective study demonstrated little effect of umifenovir on improving clinical consequences in non-ICU patients [201] , suggesting more trials for accessing the effects of umifenovir in COVID-19.Chloroquine (CQ) and hydroxychloroquine (HCQ) are used to prevent/treat malaria."
eidos
"Current status of clinical trial studies on the interventions against COVID-19 across the world as of July 31 , 2020 ( Source : National Institute of Health , https://clinicaltrials.gov/ ) Accessed on Aug 1 , 2020 Hydroxychloroquine is FDA-approved to prevent and treat malaria , as well as to treat the autoimmune diseases rheumatoid arthritis and lupus [ 44-48 ] ."
| PMC
eidos
"Both chloroquine and hydroxychloroquine are used to prevent and treat malaria , being some of the antimalarial drugs of choice in areas where the disease is not resistant to them ( a recurrent problem in this disease ) ; they were preferred over quinine because of much less severe adverse effects , although at present there are many other even safer alternative drugs for the treatment of malaria ."